JP2009519212A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009519212A5 JP2009519212A5 JP2008537892A JP2008537892A JP2009519212A5 JP 2009519212 A5 JP2009519212 A5 JP 2009519212A5 JP 2008537892 A JP2008537892 A JP 2008537892A JP 2008537892 A JP2008537892 A JP 2008537892A JP 2009519212 A5 JP2009519212 A5 JP 2009519212A5
- Authority
- JP
- Japan
- Prior art keywords
- xaa
- ome
- hsdavfteqy
- seq
- peg20k
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73029105P | 2005-10-26 | 2005-10-26 | |
| US74034205P | 2005-11-29 | 2005-11-29 | |
| US74336406P | 2006-02-28 | 2006-02-28 | |
| PCT/US2006/041550 WO2007050651A1 (en) | 2005-10-26 | 2006-10-24 | Selective vpac2 receptor peptide agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009519212A JP2009519212A (ja) | 2009-05-14 |
| JP2009519212A5 true JP2009519212A5 (enExample) | 2009-12-17 |
Family
ID=37716005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008537892A Pending JP2009519212A (ja) | 2005-10-26 | 2006-10-24 | 選択的ｖｐａｃ２受容体ペプチドアゴニスト |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7582608B2 (enExample) |
| EP (1) | EP1942941A1 (enExample) |
| JP (1) | JP2009519212A (enExample) |
| KR (1) | KR101057284B1 (enExample) |
| CN (1) | CN101296708B (enExample) |
| AU (1) | AU2006306236B2 (enExample) |
| BR (1) | BRPI0617740A2 (enExample) |
| CA (1) | CA2627716A1 (enExample) |
| EA (1) | EA012930B1 (enExample) |
| IL (1) | IL189922A0 (enExample) |
| NO (1) | NO20082345L (enExample) |
| WO (1) | WO2007050651A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10328316A1 (de) | 2003-06-23 | 2005-01-20 | Grünenthal GmbH | Verfahren zur Herstellung von Dimethyl-(3-aryl-buthyl)-aminverbindungen als pharmazeutische Wirkstoffe |
| WO2006023367A1 (en) * | 2004-08-18 | 2006-03-02 | Eli Lilly And Company | Selective vpac2 receptor peptide agonists |
| US20090170775A1 (en) * | 2004-10-08 | 2009-07-02 | Transition Therapeutics, Inc. | Vasoactive intestinal polypeptide compositions |
| US7595294B2 (en) | 2004-10-08 | 2009-09-29 | Transition Therapeutics, Inc. | Vasoactive intestinal polypeptide pharmaceuticals |
| DE102005052588A1 (de) * | 2005-11-02 | 2007-05-10 | Grünenthal GmbH | Verfahren zur Herstellung substituierter Dimethyl-(3-aryl-butyl)-amin-Verbindungen mittels homogener Katalyse |
| US20130172274A1 (en) | 2005-12-20 | 2013-07-04 | Duke University | Methods and compositions for delivering active agents with enhanced pharmacological properties |
| TWI496762B (zh) | 2006-07-24 | 2015-08-21 | 歌林達股份有限公司 | 製備（１ｒ，２ｒ）-３-（３-二甲胺基-１-乙基-２-甲基-丙基）-酚之方法 |
| CN105727261A (zh) | 2008-06-27 | 2016-07-06 | 杜克大学 | 包含弹性蛋白样肽的治疗剂 |
| IN2012DN02120A (enExample) * | 2009-08-14 | 2015-08-21 | Phasebio Pharmaceuticals Inc | |
| MY159958A (en) * | 2009-12-18 | 2017-02-15 | Idenix Pharmaceuticals Inc | 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors |
| ES2669190T3 (es) | 2011-06-06 | 2018-05-24 | Phasebio Pharmaceuticals, Inc. | Uso de péptidos intestinales vasoactivos modificados en el tratamiento de la hipertensión |
| EP3139949B1 (en) | 2014-05-08 | 2020-07-29 | Phasebio Pharmaceuticals, Inc. | Compositions comprising a vip-elp fusion protein for use in treating cystic fibrosis |
| ES2822598T3 (es) | 2015-02-09 | 2021-05-04 | Phasebio Pharmaceuticals Inc | Métodos y composiciones para tratar enfermedades y trastornos musculares |
| WO2021200259A1 (ja) * | 2020-03-30 | 2021-10-07 | 一丸ファルコス株式会社 | Ｖｉｐｒ２アンタゴニストペプチド |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04193896A (ja) * | 1989-10-26 | 1992-07-13 | Meiji Seika Kaisha Ltd | 活性ペプチド |
| JPH0692991A (ja) * | 1991-02-28 | 1994-04-05 | Daicel Chem Ind Ltd | 新規活性ペプチド |
| WO1998002453A2 (en) | 1996-07-15 | 1998-01-22 | Universite Libre De Bruxelles | Peptidic ligands having a higher selectivity for the vip1 receptor than for the vip2 receptor |
| US6242563B1 (en) | 1998-07-20 | 2001-06-05 | Societe De Conseils De Recherches Et D'applications Scientifiques, Sas | Peptide analogues |
| DE69941708D1 (de) | 1998-07-20 | 2010-01-07 | Ipsen Pharma | Pacap-peptidanaloga |
| US20030087820A1 (en) * | 1999-01-14 | 2003-05-08 | Young Andrew A. | Novel exendin agonist formulations and methods of administration thereof |
| BR0010705A (pt) | 1999-04-30 | 2002-02-05 | Amylin Pharmaceuticals Inc | Exendinas modificadas e agonistas da exendina |
| DE60039111D1 (de) | 1999-09-28 | 2008-07-17 | Bayer Corp | Agonisten des rezeptors 3 (r3) von pituitary adenylate cyclase aktivierendem peptid (pacap) und ihre pharmakologische verwendung |
| AR038102A1 (es) | 2002-01-08 | 2004-12-29 | Lilly Co Eli | Analogos extendidos de peptido 1 de tipo glucagon |
| US7378494B2 (en) * | 2002-07-12 | 2008-05-27 | Bayer Healthcare Ag | Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonist peptide |
| US7557183B2 (en) * | 2003-03-19 | 2009-07-07 | Eli Lilly And Company | Polyethylene glycol linked GLP-1 compounds |
| JP2007537141A (ja) * | 2003-12-18 | 2007-12-20 | ノボ ノルディスク アクティーゼルスカブ | 新規なｇｌｐ−１化合物 |
| JP2007519739A (ja) * | 2004-01-27 | 2007-07-19 | バイエル・フアーマシユーチカルズ・コーポレーシヨン | 下垂体細胞アデニル酸シクラーゼ活性化ペプチド（ｐａｃａｐ）受容体（ｖｃａｐ２）アゴニストおよびそれらの製薬学的使用方法 |
| CA2567635A1 (en) * | 2004-05-21 | 2005-12-01 | Eli Lilly And Company | Selective vpac2 receptor peptide agonists |
| WO2005113594A1 (en) * | 2004-05-21 | 2005-12-01 | Eli Lilly And Company | Selective vpac2 receptor peptide agonists |
| WO2006023367A1 (en) * | 2004-08-18 | 2006-03-02 | Eli Lilly And Company | Selective vpac2 receptor peptide agonists |
| WO2008043102A2 (en) | 2006-10-06 | 2008-04-10 | Transition Therapeutics Inc. | Vasoactive intestinal polypeptide compositions |
| KR20070067136A (ko) | 2004-10-08 | 2007-06-27 | 포베스 메디-테크 (리서치) 인코포레이티드 | 혈관작용성 장내 폴리펩티드 제약 |
| US7595294B2 (en) | 2004-10-08 | 2009-09-29 | Transition Therapeutics, Inc. | Vasoactive intestinal polypeptide pharmaceuticals |
-
2006
- 2006-10-24 KR KR1020087010055A patent/KR101057284B1/ko not_active Expired - Fee Related
- 2006-10-24 WO PCT/US2006/041550 patent/WO2007050651A1/en not_active Ceased
- 2006-10-24 US US12/090,656 patent/US7582608B2/en not_active Expired - Fee Related
- 2006-10-24 EP EP06817361A patent/EP1942941A1/en not_active Withdrawn
- 2006-10-24 CN CN2006800398953A patent/CN101296708B/zh not_active Expired - Fee Related
- 2006-10-24 BR BRPI0617740-9A patent/BRPI0617740A2/pt not_active IP Right Cessation
- 2006-10-24 CA CA002627716A patent/CA2627716A1/en not_active Abandoned
- 2006-10-24 JP JP2008537892A patent/JP2009519212A/ja active Pending
- 2006-10-24 AU AU2006306236A patent/AU2006306236B2/en not_active Expired - Fee Related
- 2006-10-24 EA EA200801180A patent/EA012930B1/ru not_active IP Right Cessation
-
2008
- 2008-03-04 IL IL189922A patent/IL189922A0/en unknown
- 2008-05-23 NO NO20082345A patent/NO20082345L/no not_active Application Discontinuation
-
2009
- 2009-07-24 US US12/508,584 patent/US7897573B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110229216B (zh) | 具有改善的药代动力学性质的坎普他汀类肽 | |
| KR102812908B1 (ko) | 인크레틴 유사체의 제조 방법 | |
| DK2424557T3 (en) | MODIFIED COMPSTATIN WITH PEPTID BACKBONE AND C-TERMINAL MODIFICATIONS | |
| WO2010034029A1 (en) | Peptidomimetic macrocycles | |
| CN102171243A (zh) | N-端修饰的葡萄糖依赖性促胰岛素多肽(gip)类似物 | |
| CN115925790A (zh) | 用于合成α4β7肽拮抗剂的方法 | |
| JP2006525288A5 (enExample) | ||
| WO2017023933A2 (en) | Peptidomimetic macrocycles | |
| JP2023551122A5 (enExample) | ||
| CN101437836B (zh) | 肽的硫酯化合物的制造方法 | |
| JP2005516996A5 (enExample) | ||
| AU2006306236B2 (en) | Selective VPAC2 receptor peptide agonists | |
| CN109134610B (zh) | 一种肽类化合物、其应用及含其的组合物 | |
| CA2584805C (en) | Peptide anti-tumor agent | |
| WO2007021498A1 (en) | Selective vpac2 receptor peptide agonists | |
| CN114539358B (zh) | 一种多肽及制备方法与应用 | |
| WO2026009243A1 (en) | An improved process for the preparation of tirzepatide by using hybrid approach | |
| WO2025052429A1 (en) | An improved process for the preparation of tirzepatide | |
| CN121285571A (zh) | Glp-1/gip双重、glp-1/gcg双重和glp-1/gip/gcg三重受体激动剂 | |
| HU211694A9 (en) | Hexapeptides with sulphate ester groups | |
| Human | iolo ical e affilation of ne ar inine ao re in P analo e containin non nat ral a ino acid | |
| WO1992019644A1 (fr) | Peptide vasodilatateur | |
| WO1998043995A1 (en) | Novel anti-hiv complexes and medicinal compositions | |
| HK40013212A (en) | Compstatin peptides with improved pharmacokinetic properties | |
| Klasová et al. | Effect of N-methylation of the peptide bond in the C-terminal part of the B-chain of human insulin on biological activity |